CD8A and neoplasm: However, low expression of MHC class I molecules in tumour cells leads to the loss of efficient MHC class I-mediated antigen presentation and thereby promotes tumour cell evasion of immune surveillance and inhibits CD8+ T-cell infiltration [196–198].